Silvia Buriolla
@bubisilvi
|MD| Medical Oncologist @AziendaSanitariaUniversitariaFriuliCentrale|Instagram @silviaburiolla |
ID: 738845293089849345
03-06-2016 21:30:19
23 Tweet
64 Takipçi
95 Takip Edilen
Melanoma patients treated with systemic anti cancer therapy in the End-of-life (EoL) are more frequently hospitalized due to adverse event with higher cost and delayed palliative care referral. Take a look at the data presented at #ESMO2023 Università di Udine ESMO - Eur. Oncology